Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,715,411 | 6,494,953 | 1,676,813 | 2,060,400 | 2,132,745 |
| Marketable Securities | 2,171,480 | N/A | N/A | N/A | N/A |
| Other current assets | 113,173 | 236,875 | 121,774 | 86,123 | 54,250 |
| TOTAL | $5,000,064 | $6,731,828 | $1,798,587 | $2,146,523 | $2,186,995 |
| Non-Current Assets | |||||
| PPE Net | 12,056 | 15,322 | 39,086 | 25,905 | 14,749 |
| Investments And Advances | 302,939 | 247,753 | 304,317 | 325,834 | 289,541 |
| Intangibles | 0 | 0 | 144,881 | 0 | 0 |
| Other Non-Current Assets | 121,881 | 227,579 | 102,733 | 86,867 | 98,407 |
| TOTAL | $436,876 | $490,654 | $591,017 | $438,606 | $402,697 |
| Total Assets | $5,436,940 | $7,222,482 | $2,389,604 | $2,585,129 | $2,589,692 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 40,720 | N/A | N/A |
| Accounts payable and accrued liabilities | 23,691 | 14,029 | 37,830 | 34,583 | 20,550 |
| Accrued Expenses | 114,294 | 119,417 | 167,129 | 127,531 | 76,936 |
| Other current liabilities | 1,584 | 13,941 | 15,076 | 10,855 | 103,244 |
| TOTAL | $149,411 | $266,758 | $272,448 | $184,367 | $218,961 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 375,515 | 210,025 | 170,280 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 5,918 |
| Other Non-Current Liabilities | 285,084 | 624,915 | 240,487 | 230,648 | 251,936 |
| TOTAL | $100,331 | $507,195 | $509,569 | $361,819 | $331,217 |
| Total Liabilities | $249,742 | $773,953 | $782,017 | $546,186 | $550,178 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 679,806 | 738,722 | 766,812 | N/A | N/A |
| Retained earnings | 116,060 | 576,172 | -3,772,754 | -2,763,724 | -1,918,462 |
| Other shareholders' equity | 509,031 | 475,865 | 447,204 | 381,053 | 143,171 |
| TOTAL | $5,187,198 | $6,448,529 | $1,607,587 | $2,038,943 | $2,039,514 |
| Total Liabilities And Equity | $5,436,940 | $7,222,482 | $2,389,604 | $2,585,129 | $2,589,692 |